By:
On:
In: Disease management and control

HBV infection is global health problem with over 350 million HBV carriers worldwide and over one million deaths occurring annually. Current therapy which includes IFN-alpha and nucleoside analogs such as lamivudine are partially effective. And that’s where RNA Interference comes in.Continue Reading